These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 28522244)

  • 1. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
    Suen K; Westh RN; Churilov L; Hardidge AJ
    J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
    Wilson DG; Poole WE; Chauhan SK; Rogers BA
    Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wound complications and bleeding with new oral anticoagulants in patients undergoing total joint arthroplasty: A systematic review and meta-analysis of randomized controlled trials.
    Wang M; Xie J; Zheng H; Wang S; Zhou R; Li W; Xue E; Wang X; Jiang J; Wu T; Zhan S
    Br J Clin Pharmacol; 2022 Feb; 88(2):500-513. PubMed ID: 34322914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
    Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
    Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis.
    Gao JH; Chu XC; Wang LL; Ning B; Zhao CX
    Medicine (Baltimore); 2017 Oct; 96(40):e8059. PubMed ID: 28984761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence.
    Lanitis T; Leipold R; Hamilton M; Rublee D; Quon P; Browne C; Cohen AT
    Clin Ther; 2016 Mar; 38(3):478-93.e1-16. PubMed ID: 26922297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Reported Outcomes in Industry-Funded vs Nonfunded Studies Assessing Thromboprophylaxis After Total Joint Arthroplasty.
    Groff H; Azboy I; Parvizi J
    J Arthroplasty; 2018 Nov; 33(11):3398-3401. PubMed ID: 30017220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.
    Gómez-Outes A; Terleira-Fernández AI; Suárez-Gea ML; Vargas-Castrillón E
    BMJ; 2012 Jun; 344():e3675. PubMed ID: 22700784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants for venous thromboembolism in cancer patients: a systematic review and network meta-analysis.
    Wu S; Lv M; Chen J; Jiang S; Chen M; Fang Z; Zeng Z; Qian J; Xu W; Guan C; Zhang J
    Support Care Cancer; 2022 Dec; 30(12):10407-10420. PubMed ID: 36318341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and a network meta-analysis.
    Feng W; Wang X; Huang D; Lu A
    Pharmacol Res; 2021 Apr; 166():105438. PubMed ID: 33540046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Tolerability of Anticoagulants for Thromboprophylaxis after Major Joint Surgery: a Network Meta-Analysis.
    Wang Z; Zheng J; Zhao Y; Xiang Y; Chen X; Jin Y
    Cell Physiol Biochem; 2017; 42(5):1999-2020. PubMed ID: 28793291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM; Silva MA; Donovan JL; Kanaan AO
    Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT; Hamilton M; Bird A; Mitchell SA; Li S; Horblyuk R; Batson S
    PLoS One; 2016; 11(8):e0160064. PubMed ID: 27487187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective Cohort Comparative Study of Rivaroxaban, Dabigatran, and Apixaban Oral Thromboprophylaxis in 2431 Hip and Knee Arthroplasty Patients: Primary Efficacy Outcomes and Safety Profile.
    Highcock AJ; As-Sultany M; Finley R; Donnachie NJ
    J Arthroplasty; 2020 Nov; 35(11):3093-3098. PubMed ID: 32674939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Surgical Site Infection Risk Between Warfarin, LMWH, and Aspirin for Venous Thromboprophylaxis in TKA or THA: A Systematic Review and Meta-Analysis.
    Hughes LD; Lum J; Mahfoud Z; Malik RA; Anand A; Charalambous CP
    JBJS Rev; 2020 Dec; 8(12):e20.00021. PubMed ID: 33347014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis on efficacy and safety of new oral anticoagulants for venous thromboembolism prophylaxis in elderly elective postarthroplasty patients.
    Pathak R; Giri S; Karmacharya P; Aryal MR; Poudel DR; Ghimire S; Jehangir A; Shaikh B; Rettew A; Donato AA
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):934-9. PubMed ID: 26258674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
    Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
    J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.